We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations


Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

SBRI - Annual Review

The Small Business Research Initiative - SBRI Healthcare - launched their annual review at this year's NHS Expo. The report sets out the impact of the programme over the year but also provides a summary of the outcomes achieved in the period of the AHSN leadership (approx. four years).  It has been produced by the Eastern AHSN, which leads the SBRI initiative. 

The programme has been able to evidence a pipeline of over 100 co-developed products that matched NHS needs with over 20 being adopted and used in the NHS. These products are starting to impact patient care and the potential value to the NHS was independently evaluated by the Office of Health Economics with a value to the NHS of £1.5bn.  The economic impact of these investments are also showing potential with over 420 jobs created or safeguarded delivering an economic impact of over £33m for the UK economy.  When added to the private sector investment of £45m this shows the NHS funding has had real economic impact even at this early stage in the process.

Read the annual review.